HLA-DRB1

HLA-DRB1
Name	HLA-DRB1
Gene	DRB1
Organism	Human
Uniprot	P01911

HLA-DRB1 is a human gene encoding a beta-chain component of a major histocompatibility complex class II molecule involved in antigen presentation. The locus plays a central role in adaptive immunity through peptide binding and T cell receptor engagement, and it has been studied across clinical, population, and evolutionary contexts. Research on the locus intersects with investigations by institutions such as the National Institutes of Health, Wellcome Trust, Max Planck Society, and consortia including the 1000 Genomes Project and the International HapMap Project.

Function and Molecular Structure

The protein encoded at this locus forms a heterodimer with an alpha chain to create an MHC class II molecule that presents peptides to CD4+ T lymphocytes, a process examined in studies by Edward Jenner-era vaccinology historians and modern groups at the Centers for Disease Control and Prevention, World Health Organization, and laboratories at Harvard University and Stanford University. Structural characterization using X-ray crystallography by teams associated with Max Perutz-style protein laboratories and facilities such as the European Synchrotron Radiation Facility revealed the peptide-binding groove, beta-sheet floor and alpha-helical walls that accommodate antigenic peptides, paralleling analyses performed on class II molecules like those in studies led by Peter C. Doherty and Rolf Zinkernagel. The extracellular domain includes the peptide-binding region, while transmembrane and cytoplasmic segments engage intracellular trafficking machinery studied in cell biology labs at Cold Spring Harbor Laboratory and EMBL. Interactions with CD4 T cell receptors and co-receptors have been explored in collaborations involving researchers from Massachusetts Institute of Technology and Johns Hopkins University.

Genetic Organization and Polymorphism

The gene maps within the human leukocyte antigen region on chromosome 6p21.3, a genomic neighborhood densely annotated by the Human Genome Project and databases curated by the National Human Genome Research Institute. It resides among class II loci including DR alpha and other DR beta genes in a complex haplotype architecture characterized by linkage disequilibrium observed in datasets from the HapMap Project and population surveys by the Human Genome Diversity Project. High allelic diversity arises from point mutations, gene conversion, and recombination events similar to those analyzed in evolutionary studies by the Smithsonian Institution and computational groups at the European Bioinformatics Institute. Polymorphism concentrates in exons encoding the peptide-binding region, with molecular evolution analyses drawing on comparative work involving species collections at the Natural History Museum, London and conservation genetics labs at the Salk Institute.

Alleles and Nomenclature

Allelic variants are designated by a standardized nomenclature system developed through collaboration among the World Health Organization Nomenclature Committee, the American Society for Histocompatibility and Immunogenetics, and registries maintained by groups at the Anthony Nolan Trust and the Be The Match program administered by the National Marrow Donor Program. Nomenclature conveys allele group and specific protein-coding changes, a convention comparable to naming systems used by the International Committee on Taxonomy of Viruses and databases at the European Molecular Biology Laboratory. Allelic catalogs have been compiled in reference panels used by investigators at the Broad Institute and the Wellcome Sanger Institute for association analyses in cohorts assembled by consortia like the UK Biobank and the Framingham Heart Study.

Clinical Associations and Disease Susceptibility

Variants at the locus are implicated in susceptibility and protection for multiple autoimmune and inflammatory conditions investigated in clinical centers such as Mayo Clinic, Cleveland Clinic, Karolinska Institutet, and the National Institutes of Health Clinical Center. Associations include linkage with rheumatoid arthritis examined in cohorts from Johns Hopkins, ankylosing spondylitis cohorts studied at Oxford University, multiple sclerosis research at the Karolinska University Hospital, and type 1 diabetes studies coordinated by groups at Imperial College London and University of Cambridge. The locus also contributes to outcomes in infectious disease contexts assessed by investigators at the Pasteur Institute and seroepidemiology studies by the London School of Hygiene & Tropical Medicine. Pharmacogenomic implications have emerged in trials sponsored by organizations including the National Institute for Health and Care Research and industry partners like GlaxoSmithKline and Pfizer.

Transplantation and Immunogenetics

Matching of alleles at this locus is a critical parameter in hematopoietic stem cell transplantation and solid-organ transplantation programs run by institutions such as St. Jude Children's Research Hospital, the Mayo Clinic Transplant Center, and registries like the European Society for Blood and Marrow Transplantation and the National Marrow Donor Program. Compatibility assessments employ high-resolution typing methods developed in laboratories at Stanford University and diagnostic companies like Thermo Fisher Scientific and Illumina, with clinical algorithms implemented at transplant centers including Mount Sinai Hospital and UCLA Health. Allorecognition and graft-versus-host disease risk stratification integrate HLA typing data alongside immunosuppressive regimens studied in trials registered with the Food and Drug Administration and overseen by institutional review boards from institutions such as Yale University.

Population Distribution and Evolutionary Genetics

Allelic frequencies show marked geographic and ethnic variation documented in surveys by the 1000 Genomes Project, the International HapMap Project, and national biobanks including the UK Biobank and the Japanese Biobank. Patterns reflect demographic history, selection pressures including pathogen-driven balancing selection explored in work connected to Charles Darwin-inspired evolutionary theory and empirical studies by researchers at the Max Planck Institute for Evolutionary Anthropology. Phylogeographic analyses integrate data from population geneticists at University of California, Berkeley and the University of Oxford to reconstruct migration and admixture events mirrored in allele distributions across continents studied by teams at the Smithsonian Tropical Research Institute and the Australian National University. Conservation of key residues across primates has been evaluated in comparative genomics projects involving the Broad Institute and sequence repositories curated by the National Center for Biotechnology Information.

Category:Human genes